Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Therapeutic Solutions International Inc TSOI

Therapeutic Solutions International, Inc. is focused on immune modulation for the treatment of several specific diseases. The Company is developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, and traumatic brain injury (TBI), and for daily health. Its flagship product, QuadraMune, is a multi-patented synergistic blend of pterostilbene... see more

Recent & Breaking News (OTCPK:TSOI)

Therapeutic Solutions International Announces Clinical Proof of Concept of Nanoparticle Pterostilbene Formulation: NanoStilbene™

GlobeNewswire July 2, 2018

Therapeutic Solutions International Releases "IsoStilbene" Injectable Formulation of Pterostilbene Under Granted Patent for Augmentation of Immunotherapy and Targeting of Cancer Stem Cells

GlobeNewswire June 25, 2018

Therapeutic Solutions International Announces the Appointment of James Veltmeyer, MD as Chief Medical Officer

GlobeNewswire June 18, 2018

Therapeutic Solutions International Expands Adoptive Immunotherapy Portfolio by Incorporation of "Universal Cancer Antigen" into StemVacs Dendritic Cell Platform

GlobeNewswire June 11, 2018

Therapeutic Solutions International Announces Licensing of Additional Technologies to Pan American Cancer Treatment Center

GlobeNewswire June 6, 2018

Therapeutic Solutions International to Provide Patients Access to StemVacs Cancer Immunotherapy through Newly Passed Right to Try Law

GlobeNewswire May 31, 2018

Therapeutic Solutions International, Inc., to Initiate Clinical Trial of Patented Cancer Immunotherapy Adjuvant NanoStilbene

GlobeNewswire May 15, 2018

Therapeutic Solutions International, Inc., Announces the Appointment of Nassir Azimi, MD, to Science Board

GlobeNewswire May 9, 2018

Therapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial with Pan Am Cancer Treatment Centers

GlobeNewswire May 1, 2018

Therapeutic Solutions International Develops "NanoStilbene" Nanoparticle Formulation of Pterostilbene

GlobeNewswire March 5, 2018

Therapeutic Solutions International, Inc. Recruits Top Doctor of San Diego to Scientific Advisory Board

PR Newswire February 27, 2018

Therapeutic Solutions International Returns to Fully Reporting Status with SEC

Marketwired July 6, 2017

Therapeutic Solutions Subsidiary, SandBox Dental Labs, files 510(k) with FDA

Marketwired June 26, 2017

Therapeutic Solutions International Announces Exclusive Patent License Agreement with Subsidiary Emvolio, Inc.

Marketwired June 12, 2017

Therapeutic Solutions files Patent on Methods of Re-Activating Dormant Memory Cells with Anticancer Activity

Marketwired June 5, 2017

Therapeutic Solutions International Announces Exclusive Patent License Agreement with Subsidiary Emvolio, Inc.

Marketwired June 1, 2017

Therapeutic Solutions files new Patent on Augmentation of Anti-Tumor Immunity by Mifepristone and Analogues Thereof

Marketwired May 22, 2017

Therapeutic Solutions files Patent on Blood Derived Innate Immune System Stimulator

Marketwired May 16, 2017

Therapeutic Solutions International Announces Exclusive Patent License Agreement with its Subsidiary Emvolio, Inc.

Marketwired May 10, 2017

Therapeutic Solutions files new Patent on Targeting the Tumor Microenvironment through Nutraceutical Based Immunoadjuvants

Marketwired May 9, 2017